B. Braun Medical Inc. received U.S. Food and Drug Administration approval to offer broad-spectrum intravenous antibiotics in its DUPLEX® Container. DUPLEX® is designed to simplify intravenous delivery, minimize the potential for medication errors, eliminate the pharmacy labor component of IV delivery, and reduce drug waste. Read more: http://bit.ly/1dkASzh
Client & Alumni News
B. Braun Receives FDA Approval to Offer IV Antibiotic in its Innovative DUPLEX Container
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.